120 related articles for article (PubMed ID: 12841683)
21. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells.
Mimeault M; Johansson SL; Vankatraman G; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
Mol Cancer Ther; 2007 Mar; 6(3):967-78. PubMed ID: 17363490
[TBL] [Abstract][Full Text] [Related]
22. EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines.
Tsatas D; Kanagasundaram V; Kaye A; Novak U
J Clin Neurosci; 2002 May; 9(3):282-8. PubMed ID: 12093135
[TBL] [Abstract][Full Text] [Related]
23. Urokinase induces receptor mediated brain tumor cell migration and invasion.
MacDonald TJ; DeClerck YA; Laug WE
J Neurooncol; 1998 Dec; 40(3):215-26. PubMed ID: 10066093
[TBL] [Abstract][Full Text] [Related]
24. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynolds LM
J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
[TBL] [Abstract][Full Text] [Related]
25. Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation.
Bonaccorsi L; Marchiani S; Muratori M; Forti G; Baldi E
J Cancer Res Clin Oncol; 2004 Oct; 130(10):604-14. PubMed ID: 15258753
[TBL] [Abstract][Full Text] [Related]
26. Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.
Angelucci A; D'Ascenzo S; Festuccia C; Gravina GL; Bologna M; Dolo V; Pavan A
Clin Exp Metastasis; 2000; 18(2):163-70. PubMed ID: 11235992
[TBL] [Abstract][Full Text] [Related]
27. Enhanced effect of epidermal growth factor on pulmonary metastasis and in vitro invasion of rat mammary carcinoma cells.
Hamada J; Nagayasu H; Takayama M; Kawano T; Hosokawa M; Takeichi N
Cancer Lett; 1995 Mar; 89(2):161-7. PubMed ID: 7889524
[TBL] [Abstract][Full Text] [Related]
28. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
[TBL] [Abstract][Full Text] [Related]
29. Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells.
Chakrabarty S; Rajagopal S; Huang S
Clin Exp Metastasis; 1995 May; 13(3):191-5. PubMed ID: 7750206
[TBL] [Abstract][Full Text] [Related]
30. Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer.
Banyard J; Chung I; Migliozzi M; Phan DT; Wilson AM; Zetter BR; Bielenberg DR
BMC Cancer; 2014 May; 14():387. PubMed ID: 24885350
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cells.
Shirk AJ; Kuver R
BMC Gastroenterol; 2005 Mar; 5():12. PubMed ID: 15801978
[TBL] [Abstract][Full Text] [Related]
32. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
Jo M; Thomas KS; Marozkina N; Amin TJ; Silva CM; Parsons SJ; Gonias SL
J Biol Chem; 2005 Apr; 280(17):17449-57. PubMed ID: 15728176
[TBL] [Abstract][Full Text] [Related]
33. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
Colella R; Jackson T; Goodwyn E
Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures.
Vicentini C; Festuccia C; Gravina GL; Angelucci A; Marronaro A; Bologna M
J Cancer Res Clin Oncol; 2003 Mar; 129(3):165-74. PubMed ID: 12712332
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
Sherwood ER; Van Dongen JL; Wood CG; Liao S; Kozlowski JM; Lee C
Br J Cancer; 1998 Mar; 77(6):855-61. PubMed ID: 9528825
[TBL] [Abstract][Full Text] [Related]
36. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
Li CC; Yao HT; Cheng FJ; Hsieh YH; Lu CY; Wu CC; Liu KL; Chang JW
Nutr Cancer; 2015; 67(5):771-82. PubMed ID: 25970488
[TBL] [Abstract][Full Text] [Related]
37. Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
Jo M; Thomas KS; Takimoto S; Gaultier A; Hsieh EH; Lester RD; Gonias SL
Oncogene; 2007 Apr; 26(18):2585-94. PubMed ID: 17043637
[TBL] [Abstract][Full Text] [Related]
38. In vitro anti-proliferative and anti-invasive role of aminoterminal fragment of urokinase-type plasminogen activator on 8701-BC breast cancer cells.
Luparello C; Del Rosso M
Eur J Cancer; 1996 Apr; 32A(4):702-7. PubMed ID: 8695276
[TBL] [Abstract][Full Text] [Related]
39. Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways.
Jones HE; Barrow D; Dutkowski CM; Goddard L; Smith C; Harper ME; Nicholson RI
Prostate; 2001 Sep; 49(1):38-47. PubMed ID: 11550209
[TBL] [Abstract][Full Text] [Related]
40. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynold LM
Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
